Trials / Recruiting
RecruitingNCT06260410
Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and safety data on the drug, gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood draw for ctDNA and circulating tumor cell collection. | During routine blood sample collection, additional blood will be drawn for analysis of ctDNA and to collect Circulating Tumor Cells. |
Timeline
- Start date
- 2024-02-20
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2024-02-15
- Last updated
- 2024-04-22
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06260410. Inclusion in this directory is not an endorsement.